Upcoming Webinars

Objectives

  • To understand what AATD is and what the consequences are for an individual with COPD

  • To identify target clientele who should be tested for AATD

  • To understand the diagnostic process

  • To understand the treatment, including augmentation therapy, as well as long-term adherence and lifestyle improvements to live better with AATD

Miriam Barrecheguren, MD, PhD

Friday June 7, 2019 - 12 PM to 1 PM EST

Miriam Barrecheguren, MD, PhD is a pneumologist who currently works at Vall d’Hebron University Hospital in Barcelona. Her main areas of interest include COPD, AATD and mechanical ventilation. She has been a part of Alpha-1 Antitrypsin Deficiency Center at Vall d’Hebron University Hospital since 2013. After earning her Ph.D. in 2016, on the diagnosis and management of COPD and AATD in Primary Care, she fulfilled a research fellow at McGill University and was then granted a Rio Hortega grant to continue her work in Barcelona. She is the Early Career representative for the European Respiratory Society (ERS) in the European Alpha-1 research collaboration (EARCO).
Register now!

Sébastien Gagnon, MD

Monday June 10, 2019 - 3 PM to 4 PM EST

Sébastien Gagnon, MD is a respirologist who has trained at the Institut Universitaire de Cardiologie et Pneumologie de Québec (IUCPQ), in Quebec City. He is currently doing a fellowship at McGill University under the direction of Dr. Jean Bourbeau. His interests are COPD treatment, new approaches for treatment of breathlessness as well as Pulmonary Rehabilitation.
Register now!